1. Academic Validation
  2. Construction of Smart Nanotheranostic Platform Bi-Ag@PVP: Multimodal CT/PA Imaging-Guided PDT/PTT for Cancer Therapy

Construction of Smart Nanotheranostic Platform Bi-Ag@PVP: Multimodal CT/PA Imaging-Guided PDT/PTT for Cancer Therapy

  • ACS Omega. 2021 Apr 14;6(16):10723-10734. doi: 10.1021/acsomega.1c00225.
Zonglang Zhou 1 2 Jun Xie 3 Sihan Ma 4 Xian Luo 3 Jiajing Liu 3 Shengyu Wang 3 Yuqiang Chen 1 2 Jianghua Yan 3 Fanghong Luo 3
Affiliations

Affiliations

  • 1 The 174th Clinic College of People's Liberation Army, Anhui Medical University, Hefei 230031, China.
  • 2 The 73rd Army Hospital of the Chinese People's Liberation Army, Xiamen 361003, China.
  • 3 School of Medicine, Xiamen University, Xiamen 361005, China.
  • 4 College of Energy, Xiamen University, Xiamen 361005, China.
Abstract

High-efficiency nanotheranostic agents with multimodal imaging guidance have attracted considerable interest in the field of Cancer therapy. Herein, novel silver-decorated bismuth-based heterostructured polyvinyl pyrrolidone nanoparticles (NPs) with good biocompatibility (Bi-Ag@PVP NPs) were synthesized for accurate theranostic treatment, which can integrate computed tomography (CT)/photoacoustic (PA) imaging and photodynamic therapy/photothermal therapy (PDT/PTT) into one platform. The Bi-Ag@PVP NPs can enhance light absorption and achieve a better photothermal effect than bismuth NPs. Moreover, after irradiation under an 808 nm laser, the Bi-Ag@PVP NPs can efficiently induce the generation of Reactive Oxygen Species (ROS), thereby synergizing PDT/PTT to exert an efficient tumor ablation effect both in vitro and in vivo. Furthermore, Bi-Ag@PVP NPs can also be employed to perform enhanced CT/PA imaging because of their high X-ray absorption attenuation and enhanced photothermal conversion. Thus, they can be utilized as a highly effective CT/PA imaging-guided nanotheranostic agent. In addition, an excellent Antibacterial effect was achieved. After irradiation under an 808 nm laser, the Bi-Ag@PVP NPs can destroy the integrity of Escherichia coli, thereby inhibiting E. coli growth, which can minimize the risk of Infection during Cancer therapy. In conclusion, our study provides a novel nanotheranostic platform that can achieve CT/PA-guided PDT/PTT synergistic therapy and have potential Antibacterial properties. Thus, this work provides an effective strategy for further broad clinical application prospects.

Figures
Products